Please assess the completion status of the following clinical trial:

Trial Title: Glucose Control In Hematopoetic Stem Cell Transplant

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients older than 18~* Must meet standard criteria for HSCT~* If patient is known diabetic at admit the may be maintained on home sulfonylurea and insulin if randomized to the conventional arm~Exclusion Criteria:~* If on intensive arm patient must stop all oral hyperglycemic meds

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): Regular Sliding Scale Insulin administration for hyperglycemia
- Arm 2 (Type: EXPERIMENTAL): MiniMed Paradigm monitoring device for hyperglycemia

Based on this trial design, predict the completion outcome and termination type (if applicable).